Immunemodulation in Patients With Minor Head Injury

NCT00622778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2012-04-11

No results posted yet for this study

Summary

The purpose of this study is to try to prove the worth of the two (2) Serum Proteins S-100 Beta and NSE in combination with a diagnostic algorithm to help to establish diagnosis in patients with minor head injury.

Conditions

  • Head Trauma

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Vilmos Vecsei, M.D. Professor · Head of Department

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2011-05-31
Completion
2011-07-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00622778 on ClinicalTrials.gov